GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article

CIRCADIAN AND CIRCANNUAL ASPECTS OF THE COMPLEMENT CASCADE: NEW AND OLD RESULTS, DIFFERING IN SPECIFICITYKIM Y; PALLANSCH M; CARANDENTE F et al.1980; CHRONOBIOLOGIA; ISSN 0390-0037; ITA; DA. 1980; VOL. 7; NO 2; PP. 189-204; BIBL. 46 REF.Article

MODULATION OF THE ACTIVITY OF THE CLASSICAL COMPLEMENT PATHWAY C3 CONVERTASE BY SURFACE-BOUND C3 OR C5STRUNK RC; GICLAS PC.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 2; PP. 520-526; BIBL. 20 REF.Article

THE C5B-6 COMPLEX: REACTION WITH C7, C8, C9.PODACK ER; BIESECKER G; KOLB WP et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 2; PP. 484-490; BIBL. 32 REF.Article

CALCIUM BINDING PROPERTIES OF THE C1 SUBCOMPONENTS C1Q, C1R, AND C1SVILLIERS CL; ARLAUD GJ; PAINTER RH et al.1980; F.E.B.S. LETTERS; NLD; DA. 1980; VOL. 117; NO 1; PP. 289-294; BIBL. 22 REF.Article

THE UNACTIVATED FORM OF THE FIRST COMPONENT OF HUMAN COMPLEMENT, C1.GIGLI I; PORTER RR; SIM RB et al.1976; BIOCHEM. J.; G.B.; DA. 1976; PP. 541-548; H.T. 2; BIBL. 19 REF.Article

STRUCTURE AND ACTIVATION OF THE EARLY COMPONENTS OF COMPLEMENT.PORTER RR.1977; FEDER. PROC.; U.S.A.; DA. 1977; VOL. 36; NO 9; PP. 2191-2196; BIBL. 48 REF.Article

COMPLEMENT ACTIVATION IN MIGRAINE.LORD GDA; DUCKWORTH JW; CHARLESWORTH JA et al.1977; LANCET; G.B.; DA. 1977; NO 8015; PP. 781-782; BIBL. 13 REF.Article

FORMATION OF COMPLEXES COMPOSED OF C1R, C1S AND C1 INACTIVATOR IN HUMAN SERUM ON ACTIVATION OF C1LAURELL AB; JOHNSON U; MARTENSSON U et al.1978; ACTA PATHOL. MICROBIOL. SCAND., C; DNK; DA. 1978; VOL. 86; NO 6; PP. 299-306; BIBL. 37 REF.Article

GENETIC POLYMORPHISM OF SERUM COMPLEMENT COMPONENTS IN THE CHIMPANZEERAUM D; BALNER H; PETERSEN BH et al.1980; IMMUNOGENETICS; DEU; DA. 1980; VOL. 10; NO 5; PP. 455-468; BIBL. 2 P.Article

INACTIVATION DU COMPLEMENT PAR LA SALIVE DE SOURIS: DEGRADATION ENZYMATIQUE DE C2, C3, C4, C5 ET C7LECA GERALD.1978; ; FRA; DA. 1978; 58 P.: ILL.; 30 CM; BIBL. 5 P.; TH. UNIV.: SC./PARIS 6/1978Thesis

INACTIVATION OF COMPLEMENT BY MOUSE SALIVA ENZYMATIC DEGRADATION OF C2, C3, C4, C5, AND C7WEILL JC; LECA G; GIRARD JF et al.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 12; NO 4; PP. 425-435; BIBL. 22 REF.Article

GINGIVAL FLUID ANS SERUM IN PERIODANTAL DISEASES. II. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C₃, C₃ PROACTIVATOR (FACTOR B) AND C₄ IN GINGIVAL FLUID.SCHENKEIN HA; GENCO RJ.1977; J. PERIODONTOL.; U.S.A.; DA. 1977; VOL. 48; NO 12; PP. 778-784; BIBL. 34 REF.Article

FACTEURS DU COMPLEMENT DANS LE LUPUS ERYTHEMATEUX DISSEMINE.RODRIGO J; GUARDIA J; CABRE VERDIELL J et al.1977; LYON MED.; FR.; DA. 1977; VOL. 238; NO 17; PP. 303-305; ABS. ANGL.; BIBL. 7 REF.Article

KOMPLEMENTSPIEGEL BEI KINDERN MIT IDIOPATHISCH-NEPHROTISCHEM SYNDROM. (C3, C4 UND C3-AKTIVATOR). = LE TAUX DU COMPLEMENT CHEZ LES ENFANTS PRESENTANT UN SYNDROME NEPHROTIQUE IDIOPATHIQUE (C₃, C₄ ET ACTIVATEUR C₃)POLZ E; LUBEC G.1977; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1977; VOL. 12; NO 4; PP. 360-364; ABS. ANGL.; BIBL. 12 REF.Article

CLINICAL APPLICATIONS OF IMMUNOFIXATION: DETECTION AND QUANTITATION OF COMPLEMENT ACTIVATIONWHICHER JT; HIGGINSON J; RICHES PG et al.1980; J. CLIN. PATHOL.; ISSN 0021-9746; USA; DA. 1980; VOL. 33; NO 8; PP. 781-785; BIBL. 19 REF.Article

BIOSYNTHESIS OF THE COMPLEMENT COMPONENTS AND THE REGULATORY PROTEINS OF THE ALTERNATIVE COMPLEMENT PATHWAY BY HUMAN PERIPHERAL BLOOD MONOCYTESWHALEY K.1980; J. EXPER. MED.; USA; DA. 1980; VOL. 151; NO 3; PP. 501-506; BIBL. 3 P.Article

DEMONSTRATION AND QUANTITATION OF ACTIVATION OF THE FIRST COMPONENT OF COMPLEMENT IN HUMAN SERUM.ZICCARDI RJ; COOPER NR.1978; J. EXPER. MED.; U.S.A.; DA. 1978; VOL. 147; NO 2; PP. 385-395; BIBL. 1 P.Article

FUNCTIONAL AND BIOCHEMICAL PROPERTIES OF THE EARLY CLASSICAL COMPLEMENT SYSTEM OF MICE.GOLDMAN MB; BANGALORE S; GOLDMAN JN et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 1; PP. 216-224; BIBL. 20 REF.Article

UNIQUE ROLE OF THE COMPLEMENT RECEPTOR CR₁ IN THE DEGRADATION OF C3B ASSOCIATED WITH IMMUNE COMPLEXESMEDOF M; IIDA K; MOLD C et al.1982; JOURNAL OF EXPERIMENTAL MEDICINE; ISSN 0022-1007; USA; DA. 1982; VOL. 166; NO 6; PP. 1739-1754; BIBL. 48 REF.Article

ACTIVATION OF A COMPLEXE OF C1R AND C1S SUBCOMPONENTS OF HUMAN COMPLEMENT C1 BY THE THIRD SUBCOMPONENT C1QTSAU YEN LIN; FLETCHER DS.1980; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1980; VOL. 255; NO 16; PP. 7756-7762; BIBL. 36 REF.Article

MODULATION OF THE CLASSICAL PATHWAY C3 CONVERTASE BY PLASMA PROTEINS C4 BINDING PROTEIN AND C3B INACTIVATORGIGLI I; FUJITA T; NUSSENZWEIG V et al.1979; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1979; VOL. 76; NO 12; PP. 6596-6600; BIBL. 33 REF.Article

COMPLEMENT ACTIVATION BY THE PROPERDIN SYSTEM: FORMATION OF A STOICHIOMETRIC, C3 CLEAVING COMPLEX OF PROPERDIN FACTOR B WITH C3B.VOGT W; DAMES W; SCHMIDT G et al.1977; IMMUNOCHEMISTRY; G.B.; DA. 1977; VOL. 14; NO 3; PP. 201-205; BIBL. 18 REF.Article

MODE OF INTERACTION OF DIFFERENT POLYANIONS WITH THE FIRST (C1, C1), THE SECOND (C2) AND THE FOURTH (C4) COMPONENT OF COMPLEMENT. III. INHIBITION OF C4 AND C2 BINDING SITE (S) ON C1S BY POLYANIONS.LOOS M; VOLANAKIS JE; STROUD RM et al.1976; IMMUNOCHEMISTRY; G.B.; DA. 1976; VOL. 13; NO 9; PP. 789-791; BIBL. 12 REF.Article

A SIMPLE METHOD FOR ISOLATING SPECIFIC ANTIBODIES TO COMPLEMENT COMPONENTSSUCHARIT BHAKDI; KAYSER W.1981; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1981; VOL. 41; NO 3; PP. 365-376; BIBL. 16 REF.Article